Phospho-PLK1 (Thr210) Antibody

• 产品编号：CST-5472S      品牌：CST       原厂货号：5472S
• 产品分类：抗体 > 一抗 > 磷酸化抗体
• 应用分类：

描述：

Phospho-PLK1 (Thr210) Antibody 能够检测内源性苏氨酸（210位）磷酸化的PLK1蛋白。该多克隆抗体是由合成的人源的针对PLK1蛋白苏氨酸（210位）的磷酸化肽段免疫动物，采用蛋白A和多肽亲和层析技术纯化生产的。哺乳动物细胞中至少存在四种polo样激酶：PLK1，PLK2，PLK3和PLK4/SAK(1)。PLK1在有丝分裂中发挥多种作用，尤其是调节有丝分裂的进入和离开。有丝分裂促进因子(MPF)，cdc2/cyclin B1，通过cdc25C介导的cdc2去磷酸化而被激活。PLK1能够磷酸化cdc25C的第198位丝氨酸和周期蛋白B1的第133位丝氨酸，从而导致这些蛋白从细胞质向细胞核转移(2-5)。PLK1磷酸化Myt1的第426位丝氨酸和495位苏氨酸被认为能够失活Myt1，它是一种可以磷酸化cdc2第14位和15位苏氨酸的蛋白激酶(6)。Polo样蛋白激酶也可以磷酸化粘连蛋白亚基SCC1，引起染色体臂的粘连蛋白移位，促进粘连蛋白的中心体适当定位(7)。有丝分裂的退出需要激活后期促进复合物(APC)，一种负责中心体粘连蛋白清除的泛素连接酶并能够降解分离酶抑制蛋白，周期蛋白A，周期蛋白B1，极光激酶A和cdc20(9)。体外研究已表明PLK1磷酸化APC亚基Apc1，cdc16和cdc27，且被认为是一种调节有丝分裂退出的机制(10,11)。已有报道发现Asp取代第210位苏氨酸能够提高PLK1激酶活性并且延迟细胞进入有丝分裂，而Ser137Asp替代可以导致S期捕获(12)。此外，尽管发现DNA损伤能够抑制PLK1激酶活性，但是Thr210Asp突变体对于该抑制作用是抵抗的(13)。亦有报道发现PLK1的第137位丝氨酸和210位苏氨酸可以发生在体磷酸化，而DNA损伤能够阻止这些位点的磷酸化(14)。

1. Nigg, E.A. (1998) Curr. Opin. Cell Biol. 10, 776-783.
2. Toyoshima-Morimoto, F. et al. (2002) EMBO Rep. 3, 341-348.
3. Toyoshima-Morimoto, F. et al. (2001) Nature 410, 215-220.
4. Peter, M. et al. (2002) EMBO Rep. 3, 551-556.
5. Jackman, M. et al. (2003) Nat. Cell Biol. 5, 143-148.
6. Nakajima, H. et al. (2003) J. Biol. Chem. 278, 25277-25280.
7. Sumara, I. et al. (2002) Mol. Cell 9, 515-525.
8. Hauf, S. et al. (2001) Science 293, 1320-1323.
9. Peters, J.M. (1999) Exp. Cell Res. 248, 339-349.
10. Kraft, C. et al. (2003) EMBO J. 22, 6598-6609.
11. Kotani, S. et al. (1998) Mol. Cell 1, 371-380.
12. Jang, Y.J. et al. (2002) J Biol Chem 277, 44115-20.
13. Smits, V.A. et al. (2000) Nat Cell Biol 2, 672-6.
14. Tsvetkov, L. and Stern, D.F. (2005) Cell Cycle 4, 166-71.

原厂资料：

Homology

Species predicted to react based on 100% sequence homology: Monkey

Specificity / Sensitivity

Phospho-PLK1 (Thr210) Antibody detects endogenous levels PLK1 only when phosphorylated at threonine 210.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phospho-peptide corresponding to residues surrounding Thr210 of human PLK1. Antibodies are purified using protein A and peptide affinity chromatography.

Background

At least 4 distinct polo-like kinases exist in mammalian cells: PLK1, PLK2, PLK3 and PLK4/SAK (1). PLK1 apparently plays many roles during mitosis, particularly in regulating mitotic entry and exit. The mitosis promoting factor (MPF), cdc2/cyclin B1, is activated by dephosphorylation of cdc2 (Thr14/Tyr15) by cdc25C. PLK1 phosphorylates cdc25C at Ser198 and cyclin B1 at Ser133 causing translocation of these proteins from the cytoplasm to the nucleus (2-5). PLK1 phosphorylation of Myt1 at Ser426 and Thr495 has been proposed to inactivate Myt1, one of the kinases known to phosphorylate cdc2 at Thr14/Tyr15 (6). Polo-like kinases also phosphorylate the cohesin subunit SCC1, causing cohesin displacement from chromosome arms that allow for proper cohesin localization to centromeres (7). Mitotic exit requires activation of the anaphase promoting complex (APC) (8), a ubiquitin ligase responsible for removal of cohesin at centromeres, and degradation of securin, cyclin A, cyclin B1, Aurora A and cdc20 (9). PLK1 phosphorylation of the APC subunits Apc1, cdc16 and cdc27 has been demonstrated in vitro and has been proposed as a mechanism by which mitotic exit is regulated (10,11).Substitution of Thr210 with Asp has been reported to elevate PLK1 kinase activity and delay/arrest cells in mitosis, while a Ser137Asp substitution leads to S-phase arrest (12). Additionally, while DNA damage has been found to inhibit PLK1 kinase activity, the Thr210Asp mutant is resistant to this inhibition (13). PLK1 has been reported to be phosphorylated in vivo at Ser137 and Thr210 in mitosis, and DNA damage prevents phosphorylation at these sites (14). 

1. Nigg, E.A. (1998) Curr. Opin. Cell Biol. 10, 776-783.
2. Toyoshima-Morimoto, F. et al. (2002) EMBO Rep. 3, 341-348.
3. Toyoshima-Morimoto, F. et al. (2001) Nature 410, 215-220.
4. Peter, M. et al. (2002) EMBO Rep. 3, 551-556.
5. Jackman, M. et al. (2003) Nat. Cell Biol. 5, 143-148.
6. Nakajima, H. et al. (2003) J. Biol. Chem. 278, 25277-25280.
7. Sumara, I. et al. (2002) Mol. Cell 9, 515-525.
8. Hauf, S. et al. (2001) Science 293, 1320-1323.
9. Peters, J.M. (1999) Exp. Cell Res. 248, 339-349.
10. Kraft, C. et al. (2003) EMBO J. 22, 6598-6609.
11. Kotani, S. et al. (1998) Mol. Cell 1, 371-380.
12. Jang, Y.J. et al. (2002) J Biol Chem 277, 44115-20.
13. Smits, V.A. et al. (2000) Nat Cell Biol 2, 672-6.
14. Tsvetkov, L. and Stern, D.F. (2005) Cell Cycle 4, 166-71.

注意事项：

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM
NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C.
Do not aliquot the antibody.